Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on intimation of Postal Ballot Notice
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited has filed a Postal Ballot Notice with BSE seeking shareholder approval for the appointment of Ms. Jaya Ankur Singhania (DIN: 01990322) as a Non-Executive Independent Director for a term of five consecutive years, effective from March 26, 2025. The Board had appointed her on March 26, 2025, subject to shareholder approval, as required under SEBI LODR Regulations. Ms. Singhania is a 42-year-old Company Secretary with over 15 years of experience in corporate governance, legal advisory, and boardroom strategy, and currently serves on several other listed and unlisted company boards. Shareholders can vote electronically via NSDL's e-voting platform between April 4, 2025 (9:00 AM) and May 3, 2025 (5:00 PM), with results expected to be announced by May 6, 2025.
This is a routine governance filing seeking shareholder approval for a board appointment. It does not involve any capital change, financial transaction, or material business event, so the impact on the stock price is expected to be neutral. Shareholders should note the e-voting window to exercise their voting rights on this special resolution.